The commitment to advancing oncology treatment and patient care is paramount at Sunesis, and it drives every aspect of our business.
Sunesis leverages data from nonclinical and translational research to better understand vosaroxin's biology, mechanism and anticipated activity in hopes of streamlining clinical development efforts.
We stress the importance of teamwork: developing drugs is a complex, challenging process that requires open communication and a selfless pursuit of the truth. We seek to hire the best people and support them with ongoing education so they can help identify innovative solutions that will make a real difference to patients. Sunesis employees take inspiration from the real-life stories of patients who are fighting this disease and remain mindful of the true purpose of our work.
Sunesis is committed to participating in the larger community of people fighting cancer. We support philanthropic organizations whose mission is to assist patients and their loved ones. We also want to ensure that our patients are informed about their disease and how our medicines may help, and are aware of other resources that can help them.